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Abstract
During endochondral development, elongation of the bone collar occurs coordinately with growth of the underlying cartilaginous growth
plate. Transglutaminases (TGases) are upregulated in hypertrophic chondrocytes, and correlative evidence suggests a relationship between
these enzymes and mineralization. To examine whether TGases are involved in regulating mineralization/osteogenesis during bone
development, we devised a coculture system in which one cellular component (characterized as preosteoblastic) is derived from the
nonmineralized region of the bone, and the other cellular component is hypertrophic chondrocytes. In these cocultures, mineralization is
extensive, with the preosteoblasts producing the mineralized matrix, and the chondrocytes regulating this process. Secreted regulators are
involved, as conditioned medium from chondrocytes induces mineralization in preosteoblasts, but not vice versa. One factor is TGase. In
the cocultures, inhibition of TGase reduces mineralization, and addition of the enzyme enhances it. Exogenous TGase also induces markers
of osteoblastic differentiation (i.e., bone sialoprotein and osteocalcin) in the preosteoblasts, suggesting their differentiation into osteoblasts.
Two possible signaling pathways may be affected by TGase and result in increased mineralization (i.e., TGF- and protein kinase A
pathways). Addition of exogenous TGF-2 to the cocultures increases mineralization; though, when mineralization is induced by TGase,
there is no detectible elevation of TGF-, suggesting that these two factors stimulate osteogenesis by different pathways. However, an
interrelationship seems to exist between TGase and PKA-dependent signaling. When mineralization of the cocultures is stimulated through
the addition of TGase, a concomitant reduction (50%) in PKA activity occurs. Consistent with this observation, addition of an activator of
PKA (cyclic AMP) to the cultures inhibits matrix mineralization, while known inhibitors of PKA (H-89 and a peptide inhibitor) cause an
increase in mineralization. Thus, at least one mechanism of TGase stimulation probably involves inhibition of the PKA-mediated signaling.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
During the development of a long bone, the processes of
osteoblast differentiation and mineralization within the ad-
vancing bone collar must be coordinated with the growth
and differentiation of the underlying chondrocytes within
the cartilagenous growth plate. The mechanisms regulating
osteoblast differentiation and mineralization have been ex-
tensively studied, and a number of factors have been impli-
cated. These include, among others, members of the trans-
forming growth factor (TGF) family, such as TGFs and
bone morphogenic proteins (BMPs) (Thorp et al., 1992;
Horner et al., 1998; Schinke et al., 1999; Ducy and
Karsenty, 2000).
Recently, accumulating evidence implicates the transglu-
taminase enzymes (TGases) as regulators of matrix miner-
alization. The TGases (R-glutamylpeptide: amine--glu-
tamyl transferase, EC 2.3.2.13) are Ca2-dependent
enzymes that catalyze the formation of -(-glutamyl)-
lysine-protein cross-links. In mammals, they comprise a
family with at least nine members, two of which—the
plasma form (FXIIIa) and the tissue form (TGase II)—are
expressed in chondrocytes of the growth plate (Nurmin-
skaya and Linsenmayer, 1996; Aeschlimann et al., 1993)
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and in articular chondrocytes (Demignot et al., 1995;
Rosenthal et al., 2001; Nurminskaya and Linsenmayer,
2002). In the growth plate, these enzymes are upregulated in
the zone of hypertrophy, which undergoes mineralization
during the process of endochondral ossification (Aeschli-
mann et al., 1993; Nurminskaya et al., 1998). In the articular
cartilage, both enzymatic forms are upregulated when
pathological mineralization occurs, such as in osteoarthritic
conditions and also in ageing (Rosenthal et al., 1997; John-
son et al., 2001). These results suggest that TGase activity
may be involved in the regulation of matrix mineralization
both in normal and pathological conditions (reviewed by
Aeschlimann and Thomazy, 2000).
These studies, suggesting that TGase may be involved in
matrix mineralization, when coupled with recent observa-
tions we have made, raise the possibility that, during bone
development, a TGase-mediated interaction, emanating
from the hypertrophic chondrocytes (HyCho) of the growth
plate, is involved in differentiation and mineralization of the
overlaying periosteal bone. We have previously shown that
TGase, in the form of FXIIIa, is upregulated in HyCho cells
(Nurminskaya and Linsenmayer, 1996) and that, upon their
death, these cells release TGase into the extracellular matrix
(Nurminskaya et al., 1998, 2002). Furthermore, we have
observed morphologically that the advancing collar of peri-
osteal bone can be delineated into two regions: a leading
edge which overlies the nonhypertrophic chondrocytes of
the cartilagenous growth plate, and a region of mineralized
bone which begins to form over the hypertrophic zone of the
cartilage.
Based on these observations, in the present study we
examined whether HyCho cells are involved in regulating
the mineralization of the leading edge of the bone, and, if so,
whether HyCho-derived TGase may be one of the factors
regulating this process. Finally, we analyzed some of the
possible mechanisms through which TGase may regulate
mineralization.
The means through which TGase activity might affect
mineralization and bone formation is unknown. It has been
proposed that TGases may directly stabilize the cartilag-
enous matrix by cross-linking calcium-binding proteins,
and, in this manner, form a nucleation site for the growth of
calcium-containing crystals (Aeschlimann and Thomazy,
2000). Alternatively, TGases may regulate mineralization
indirectly through additional signaling pathways, such as
through activation of a latent form of TGF- (LTGF-) and
another is through protein kinase A (PKA).
Most cell types secrete TGF- in a latent form that
cannot bind to TGF- receptors (Barnard et al., 1990).
TGase is able to activate the LTGF- complex through
cross-linking of LTGF- binding protein to the extracellular
matrix. This has been proposed from studies on endothelial
cells (Kojima et al., 1993; Nunes et al., 1997), and a similar
involvement of TGase in TGF- activation has been re-
ported for articular chondrocytes (Rosenthal et al., 2000; Le
et al., 2001). Once activated, TGF- has been reported to
both stimulate and inhibit bone formation. In vivo, the local
administration of TGF- induces bone formation (Horner et
al., 1998; Ripamonti et al., 2000) and enhances bone healing
(Blumenfeld et al., 2002). Consistent with the in vivo re-
sults, the addition of TGF- to low-density cell cultures of
an osteosarcoma cell line induces enzymes associated with
calcification (e.g., alkaline phosphatase and phospholipase
A2) (Bonewald et al., 1990). Also, in cultures of hypertro-
phic chondrocytes, the endogenous levels of active TGF-
increase concomitant with increasing matrix mineralization
(D’Angelo et al., 2001). To our knowledge, the TGF-s are
the only family of signaling molecules that have been re-
ported to regulate osteogenesis and which can be activated
by TGase. In the present study, we have examined whether
TGase may regulate mineralization through the activation of
TGF-.
We have also examined the possibility of TGase-medi-
ated regulation of mineralization through the PKA pathway.
Previous studies by others show that PKA signaling regu-
lates mineralization in osteoblasts. PKA can phosphorylate
specific transcription factors and consequently affect the
transcription levels of genes, such as bone sialoprotein
(BSP), a marker of osteoblastic differentiation (Chen et al.,
1992). PKA has also been shown to mediate the paracrine
and/or autocrine effect of parathyroid hormone on cell pro-
liferation and differentiation. In two types of cells capable
of biomineralization, e.g., osteoblasts and cementoblasts,
activation of the PKA pathway has been reported to de-
crease both matrix mineralization and the expression of
bone sialoprotein (Wang et al., 2000; Ouyang et al., 2000).
We devised a coculture system in which cells from the
nonmineralized, leading edge of the bone collar are cultured
along with HyCho cells. In these cocultures, mineralization
is rapid and extensive. We characterized and defined cells
from the nonmineralizing edge as preosteoblastic (PrO-
cells) as (1) they express certain molecules characteristic of
early osteoblast development, but not ones indicative of
overt osteoblast differentiation, and (2) in the cocultures
they differentiate and acquire the characteristics of overt
osteoblasts, including the production of mineralized matrix.
Our results suggest that, in the coculture system, the HyCho
cells induce/promote the mineralization of the Pro-cells, and
that this process is effected—at least in part—through the
secretion of TGase(s). Lastly, we have examined possible
mechanisms through which TGase mediates this effect.
With respect to the possibility that this involves activation
of LTGF- by TGase, we have observed that, in the cocul-
tures, exogenous active TGF- stimulates mineralization.
However, our data show that TGase-mediated stimulation
of mineralization is independent to that produced by
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TGF-. In regards to the PKA-mediated regulation of min-
eralization, we have shown that activation of PKA decreases
matrix mineralization in the coculture system, while inhib-
itors of PKA cause an increase in matrix mineralization. We
have also observed that TGase decreases the levels of PKA
activity in cell cultures. Thus, our results suggest that the
TGase-induced increase in mineralization and osteoblastic
differentiation may be mediated through a decrease in the
level of PKA activity.
Materials and methods
Cell cultures
Cartilages were dissected from 14-day-old chicken em-
bryos (Spafas Inc., Norwich, CT). Hypertrophic chondro-
cytes were from the hypertrophic zone three (Kim and
Conrad, 1977) of the tibia. Cells were dissociated by
0.125% trypsin (Gibco BRL, Gaithersburg, MD), 0.3% col-
lagenase type I (Sigma Chemical Co., St. Louis, MO), and
0.6% bovine testes hyaluronidase type I (Sigma Chemical
Co.), and then cultured in DMEM (Gibco BRL) containing
10% bovine calf serum (Hyclone Labs, Logan, UT) and 50
U/ml penicillin and streptomycin (GIBCO BRL). The hy-
pertrophic chondrocytes were cultured for 2–4 weeks and
passaged three to four times before use.
Preosteoblastic cells (PrO) were cultured from the non-
mineralized ends of the bone collar (see Fig. 1). For this, the
tissue (from one dozen embryos) was finely minced with a
scalpel and the pieces were transferred to a 60-mm tissue
culture dish. To promote attachment of the pieces to the
plate, and the subsequent migration of the fibroblasts from
the pieces, only a small volume of medium was used during
the first 2 days in culture (0.5 ml; DMEM/10% calf serum/
penicillin/streptomycin), followed on the third day by an
additional 5 ml. Once the fibroblasts had become confluent,
they were used for experiments.
Mouse chondrocytes were from the growth plates of the
long bones of 18-day embryos. Cells were dissociated and
cultured similarly to the cultures of chicken chondrocytes.
Preparation of RNA and RT-PCR
Total RNA was isolated by using Trizol reagent (Gibco
BRL). Single-strand cDNA was synthesized from 1 mg of total
RNA by using SuperScript II reverse transcriptase (Gibco
BRL). PCR amplification was performed for 30 cycles to
analyze the gene expression with the following primers: for
chicken osteopontin, primers ATGATTCCAATGACACT-
GACGAGTC and AATGCACAGGTTCCTCTTAACGG; for
chicken osteonectin, primers AAGATGTAGAGGAGAT-
CGTCGCAG and CATTCCTCCAGGGCGATGTAC; for
chicken bone sialoprotein, primers CCGGTACTACCTG-
TACCGCTACG and TCCCACTGTCACCTCGTACTC; for
chicken osteocalcin, primers ATGCTCGCAGTGCTAAA-
GCCT and TTATTTCTGTCCATCCTTCGCG.
Real time quantitative RT-PCR was performed by using
the QuantiTect SYBR Green PCR kit (Qiagen). Reactions
were done in triplicates for each pair of primers, using the
ABI 5700 Sequence Detector. Results were analyzed by
using the Microsoft Excel program.
Enzymatic activity assays
For enzymatic assays, cells cultures (in 35-mm wells)
were lysed with 0.15 ml of ice-cold lysis buffer (5 mM
Tris/HCL, pH 7.5, 0.25 M sucrose, 0.2 mM MgSO4, 2 mM
DTT, 0.4 mM PMSF, 5 g/ml leupeptine, and 0.4% Triton
X-100). Transglutaminase activity was determined by in-
Fig. 1. Characterization of preosteoblastic cells from the nonmineralized
leading edge of the periosteal bone collar. (A) Tibias from 14-day chicken
embryos stained with Alizarin Red to visualize the mineralized bone collar.
The left side of the tibia is intact, on the right the periosteal bone has been
separated from the cartilage, revealing the nonmineralized “leading edge”
of the bone collar as a thin layer of unstained tissue. (B) RT-PCR-detection
of osteoblastic markers in cultures of cells from the leading edge of the
bone collar (lane 1) and from the mineralized periosteal bone (lane 2), used
as positive control for the PCR reaction.
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corporation of 14C-putrescine into casein, as described pre-
viously (Nurminskaya et al., 1998). Alkaline phosphatase
activity was measured by using p-nitrophenyl phosphate as
a substrate (Sigma). PKA activity was measured in cell
lysates by using biotinylated Kempeptide (LRRASLG)
from the SignaTECT cAMP-dependent protein kinase assay
system (Promega). Total protein concentration was deter-
mined with the BCA reagent (Pierce).
Biotin-pentylamine incorporation assay
The pattern of TGase-mediated protein cross-linking was
analyzed as described previously (Kaartinen et al., 2002).
Briefly, cells were grown in medium containing 0.5-1 M
5-(biotinamido)-pentylamine (bPA; Pierce). Cells were
washed twice with cold PBS and lysed with RIPA buffer
(50 l 1/35-mm well). Proteins were separated by the
SDS-acrylamide gels and transferred to PVDF membranes
(BioRad). Protein-bound biotin was detected with ExtrAvi-
din-HRP conjugate (Sigma) and developed with chemilu-
minescence (Pierce).
Mineralization assay
To induce mineralization, 5 mM glycerophosphate and
25 g/ml ascorbate were added to the culture medium
(Boskey et al., 1992, 1996). Then, 0.01 unit/ml of tissue
transglutaminase (Sigma) or 1.5 M putrescine (Sigma)
was added daily. To inhibit PKA, 10 M cell-permeable
myrisroylated protein kinase inhibitor 14–22 amide (Cal-
biochem) or 50 nM PKA inhibitor H-89 (Upstate Biotech-
nology) was added to the culture medium. To activate PKA,
40 M of cAMP analogue, 8-bromo-cAMP (Calbiochem)
was added to the medium, and to inhibit MEK1 and MEK2,
5 M U0126 (Calbiochem) was added. After 5–8 days in
culture, cells were fixed with 4% paraformaldehyde in PBS.
Mineralization (of the matrix) was visualized by the addi-
tion of an aqueous solution of Alizarin Red (0.1%) for 20
min at room temperature with subsequent washes in PBS. A
quantitative comparison of the mineralization in the differ-
ent cultures was obtained by determining the relative areas
of Alizarin Red staining in cultures. For this, a digital image
of each 35-mm culture well was taken with a Spot Camera
attached to a Leica dissecting microscope. Then, the areas
of Alizarin Red staining (expressed as pixels/35-mm culture
well) were determined by image analysis, using the Im-
agePro Software package.
Proliferation assay
Relative cell proliferation was determined by [3H]-thy-
midine incorporation. For this, cultures were labeled with
[3H]-thymidine (2 Ci/35-mm well cell culture) overnight.
The cultures were washed twice with PBS, and then 0.5 ml
of 6% TCA was added and the cultures were kept at 20°C
for a minimum of 4 h. The cultures were then thawed, rinsed
with PBS, and solubilized with 150 l of 3 M NaOH. 75
1-aliquots were counted in 5 ml of scintillation liquid
(Beckman).
Determination of TGF- present in conditioned medium
from cell cultures
Active TGF- in conditioned media from the different
cell cultures was determined by using mink lung epithelial
cells (PAI/L cells) (Abe et al., 1994) stably transfected with
a TGF--responsive plasminogen activator inhibitor-1
(PAI-1) promoter construct linked to a luciferase reporter
gene. Luciferase activity was determined by using the Pro-
mega Luciferase Assay System (Promega, Madison, WI)
and an Optocomp I luminometer (GEM Instruments, Pinev-
ille, NC). To determine total TGF- (latent and active) in
the conditioned media, the TGF- was measured before and
after heat activation (85°C for 12 min). Standard curves
were generated by using commercially available active
TGF-2 (R&D Systems, Minneapolis, MN).
Results
Mineralization in cocultures of preosteoblastic cells
and hypertrophic chondrocytes
The osteoblasts of the bone collar are derived from the
fibroblastic cells of the periosteum, a fibrous connective
tissue that surrounds the bone. In a rapidly growing and
elongating bone, such as the tibiotarsus of the 14-day
chicken embryo, the central region of the bone collar, which
is older and more developed, is mineralized; however, the
leading edge is not (Fig. 1A). The fibroblastic cells from this
nonmineralized leading edge of the bone, when grown in
primary and secondary cell cultures, show characteristics
indicative of early osteoblastic development. As detected by
RT-PCR, they express the transcription factor Cbfa1, a
regulator of osteogenic differentiation (Ducy et al., 1997),
and the extracellular proteins osteonectin and osteopontin,
the markers of early osteoblast differentiation (Quarles et
al., 1992) (Fig. 1B, left panel, lane 1). However, these cells
lack or express at very low levels certain markers consid-
ered to be characteristic of overt osteoblast differentiation,
such as osteocalcin and BSP (Raouf and Seth, 2000) (Fig.
1B, right panel, lane 1). These cells also synthesize notice-
able levels of alkaline phosphatase (Fig. 2B), one of the
enzymes associated with matrix calcification (Bonewald et
al., 1990). When cultured in a standard mineralization me-
dium containing -glycerophosphate and ascorbate, these
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cells are able to produce some mineralized matrix. How-
ever, the amounts of mineralization are small, and it appears
only after an extended period in culture (see below). There-
fore, we have defined these cells as preosteoblastic (PrO).
Mineralization in the cultures of PrO cells themselves is
minimal after 8 days in culture (the typical time in culture
before cells form multilayered sheets that lift off the plate).
By Alizarin Red staining, the 8-day-old cultures generally
have 3–6 mineralized nodules in a 35-mm dish, while after
just 5 days in culture, no mineralization can be visualized at
all (Fig. 2A, PrO). However, when these cells are cocultured
along with hypertrophic chondrocytes (HyCho), mineraliza-
tion is extensive (Fig. 2A, Pro/HyCho), averaging approx-
imately 150 mineralized nodules in a 35-mm dish. Also, the
first mineralization can be detected as early as 4 days in
culture. With time, the area of mineralized matrix (deter-
mined by image analysis) increases until day 8, when it
reaches a plateau (data not shown). Cultures of HyCho cells
themselves show no detectible mineralization (Fig. 2A, Hy-
Cho), and this is true even after 35 days of culture, the
longest time examined (data not shown).
In the cocultures, mineralization is accompanied by in-
creased levels of alkaline phosphatase (Fig. 2B, PrO/Hy-
Cho). Of potential interest, in cultures of PrO cells them-
selves (Fig. 2B, PrO), the alkaline phosphatase activity
reaches the same high level as in the mixed cultures (Fig.
2B, PrO/HyCho); however, no mineralization occurs. Thus,
increasing the production of alkaline phosphatase seems to
be an inherent property of the PrO cells, but this elevated
alkaline phosphatase per se does not result in mineraliza-
tion. Instead, these results suggest that an interaction with
HyCho cells, as occurs in the cocultures, is required to
induce mineralization. Cultures of HyCho cells themselves
have little if any detectible alkaline phosphatase (Fig. 2B,
HyCho).
In the cocultures, the extent of mineralization depends on
the ratios at which the two cell types are initially plated. The
earliest and most intense mineralization occurs with an
initial plating of the chondrocytes/PrO cells in a ratio of
10–20:1, with little if any mineralization when the ratio is
decreased to 5:1 or increased to 40:1. However, the PrO
cells proliferate in culture much more rapidly than the
HyCho cells (data not shown). Therefore, at the time they
undergo mineralization, the cocultures contain many more
PrO cells (identifiable by their fibroblastic appearance) than
HyCho cells.
The large preponderance of PrO/PrO-derived cells in the
cocultures in itself suggests that this is the cell type directly
involved in producing the mineralized matrix. We examined
this more directly using cocultures in which the chicken
HyCho cells were replaced with mouse chondrocytes (de-
rived from the prehypertrophic and hypertrophic cartilage of
18-day embryos). These cultures allowed for analysis of the
species-specific expression of BSP and osteocalcin, two
markers of advanced osteoblastic differentiation (Ducy et
al., 1997). In these cultures, mineralization occurred rapidly
(on day 7–8), but in the cultures of each individual cell type,
no mineralization was detected. When we analyzed these
cocultures by RT-PCR using chicken- and mouse-specific
primers, at the time of mineralization only chicken BSP and
osteocalcin were detected (Fig. 2C, lane 3), with none from
mouse (Fig. 2C, lane 1). [As a positive control, in these
RT-PCRs total RNA from the endochondral mineralized
bones from both species was used (data not shown).] The
increase in chicken BSP and osteocalcin expression in the
presence of mouse chondrocytes reflects the osteoblastic
maturation of the chicken PrO cells. Thus, it is the PrO cells
Fig. 2. Matrix mineralization in the cocultures of preosteoblsatic cells and
hypertrophic chondrocytes. (A) Assays for matrix mineralization (visual-
ized by Alizarin Red staining) in the 5-day-old cultures of preosteoblastic
cells (PrO); hypertrophic chondrocytes (HyCho); cocultures of preosteo-
blastic cells and hypertrophic chondrocytes (PrO/HyCho); preosteoblastic
cells cultured with the conditioned medium from the hypertrophic chon-
drocytes (PrOHyCho-CM). (B) Alkaline phosphatase activity in the
corresponding cell cultures. (C) RT-PCR analysis of bone sialoprotein
(BSP) and osteocalcin expression in chicken PrO cells and in the cocultures
of mouse chondrocytes and chicken PrO cells. The following specie-
specific primers were used: (1) mouse BSP, (2) mouse -actin, (3) chicken
BSP, (4) chicken -actin, (5) chicken BSP, and (6) chicken -actin.
Mineralized periosteal bones of the 2-day-old mice were used for the
positive control RT-PCR (data not shown).
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that differentiate into osteoblasts and most likely produce
the mineralized matrix. The HyCho cells seem to regulate/
stimulate this process (also demonstrated by the conditioned
medium experiments described next).
We examined whether this regulation requires contact
between the two cell types, or whether it is achievable
through the secretion of a diffusible factor(s) by the HyCho
cells. For this, we tested the ability of conditioned medium
(CM) from the HyCho cultures to stimulate mineralization
in cultures of PrO cells (Fig. 2A). When this conditioned
medium is added to PrO cell cultures, there is a large
increase in mineralization (in Fig. 2A compare “PrO” and
“PrOHyCho-CM”). This induction of mineralization is
accompanied by differentiation of the PrO cells into overt
osteoblasts expressing BSP, as detected by RT-PCR (data
not shown). Conversely, no mineralization was detected in
cultures of HyCho cells treated with conditioned medium
from PrO cell cultures (data not shown). Thus, HyCho cells
secrete a factor(s) that stimulates mineralization in the PrO
cells. However, this stimulation is not as great as in cocul-
tures of the two cell types (in Fig. 2A, “PrOHyCho-CM”
and “PrO/HyCho”), suggesting the existence of an addi-
tional mechanism(s) requiring contact between the two cell
types.
Transglutaminase-mediated regulation of mineralization
We next determined whether TGase was one of the
regulatory factors secreted by the HyCho cells. Previous
studies have suggested that TGase activity may regulate
mineralization, and that during the normal development of
long bones, HyCho cells are a major source of this enzy-
matic activity. In the cells employed in the present studies,
HyCho-derived TGases comprise the major source of en-
dogenous enzyme. By conventional RT-PCR, both the Hy-
Cho and PrO cell cultures contain mRNAs for TGases (Fig.
3). However, there are both qualitative and quantitative
differences. While the HyCho cells contain appreciable
amounts of mRNAs for both FXIIIa and TGaseII, the PrO
cells have considerably less mRNA for FXIIIa and none
detectible for TGaseII. Consistent with these results, anal-
yses using real-time quantitative RT-PCR showed a 6.81 
0.93-fold higher level of mRNA for FXIIIa in the HyCho
cells versus PrO cells, and approximately a 400-fold higher
level of TGase II (all normalized to mRNA for -actin).
Consistent with these determinations, the enzymatic activity
for TGase in the HyCho cell cultures is approximately
6-fold greater than in the PrO cell cultures, as assayed by
14C-putrescine incorporation into casein (data not shown).
To functionally test whether TGase can regulate matrix
mineralization, the TGase activity in the PrO/HyCho cocul-
tures was altered both by decreasing the endogenous enzy-
matic activity through the addition of the competitive in-
hibitor putrescine (1,4-diaminobutane), and by increasing
the total activity through the addition of exogenous TGase.
As can be seen in Fig. 4A, the addition of TGase (TGase)
(0.01 unit/ml) increased mineralization (as detected by Al-
izarin Red staining) by 3- to 5-fold over the untreated
cultures (in 10 experiments, P  0.05). This increase in
mineralization is reflected by similar increases both in the
number of mineralized nodules per dish (4.17  0.96-fold),
and in the total area of mineralized matrix (measured as
pixels per well) (3.9  0.65-fold).
Consistent with these results, the addition of putrescine
to inhibit the endogenous TGase activity produced the op-
posite effect, significantly reducing mineralization (Fig.
4A). It is unlikely that this reduction in mineralization is due
to any toxic side effects of putrescine, such as the inhibition
of cell proliferation that has been observed with high con-
centrations of the drug (104 M) (Gahl and Pitot, 1978).
The concentration of putrescine we used was low (106 M),
and it produced no significant change in cell proliferation, as
measured by incorporation of 3H-thymidine (Fig. 4B).
Likewise, proliferation was not involved in the increased
mineralization produced by the addition of exogenous
TGase, which remained indistinguishable from the un-
treated cultures (Fig. 4B, compare “untreated” and
“TGase”).
To test directly whether the TGase-mediated increase in
mineralization reflects the involvement of this enzyme in
the regulation of the PrO differentiation into osteoblasts, we
examined the expression of BSP in cultures of PrO cells
treated with the exogenous TGase. Control cultures of PrO
cells showed slight mineralization (as described earlier) and
had little if any mRNA for BSP (Fig. 5). However, when
these cells were grown in the presence of exogenously
added enzyme (0.01 U/ml), mRNA for BSP was clearly
detectible (Fig. 5A). Similarly, the expression of osteocalcin
was stimulated in the PrO cells by exogenous TGase (data
not shown). A concomitant increase in mineralization of
PrO cultures was also observed (Fig. 5B).
Fig. 3. RT-PCR analysis of the expression of FXIIIa and TGaseII in the
primary cultures of PrO cells. Hypertrophic chondrocytes (HyCho) were
used as a positive control.
144 M. Nurminskaya et al. / Developmental Biology 263 (2003) 139–152
Fig. 4. Effect of altered transglutaminase activity on matrix mineralization in the PrO/HyCho cocultures. The cocultures were supplemented daily with either
transglutaminase (TGase; 0.01 unit/ml) or putrescine (putrescine; 1.5 M). (A) Matrix mineralization was visualized by Alizarin Red staining in 5-day
cultures. Quantitative analysis was performed with ImagePro software on the images of areas of Alizarin Red staining). (B) Proliferation was determined by
3H-thymidine incorporation assay. The results on mineralization are expressed as fold-increase in the TGase and putrescine treated cultures versus the controls
(6 independent experiments); those on proliferation are of triplicate cultures in two separate experiments.
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Mechanisms of transglutaminase-mediated mineralization
As described in the Introduction, several possible mech-
anisms exist for the TGase-induced mineralization observed
in the cocultures. These include a direct effect in which
TGase increases mineralization by modifying extracellular
proteins, and indirect effects in which TGase affects signal-
ing through the activation of LTGF- or through alterations
in PKA signaling.
Modification of matrix proteins
Previous studies by others have suggested that TGases
may directly stabilize the cartilaginous matrix by cross-
linking calcium-binding proteins, and, in this manner, form
a nucleation site for the growth of calcium-containing crys-
tals (reviewed in Aeschlimann and Thomazy, 2000). To
address this possibility, we analyzed the pattern of TGase-
induced cross-linking in cocultures in the presence or ab-
sence of exogenously added enzyme. To identify cross-
linked proteins, we employed an assay involving in vivo
cross-linking of the TGase substrate, biotinylated pen-
tylamine, to the endogenous proteins, followed by analysis
of the profile of biotin-labeled proteins by Western blot
using the anti-biotin antibodies (Kaartinen et al., 2002).
Since we observed essentially identical patterns of the
cross-linked, biotinylated proteins in the presence or ab-
sence of exogenous TGase (Fig. 6), it is unlikely that this
mechanism plays a major role in the observed induction of
mineralization, if any role at all.
Independence of TGase and TGF-
Proteins of the TGF- family are known regulators of
osteogenesis and mineralization (Ripamonti et al., 2000;
Talley-Ronsholdt et al., 1995; Spinella-Jaegle et al., 2001).
To determine whether TGase could increase mineralization
by activating latent TGF- (LTGF-), we first examined
whether active TGF- would promote mineralization in the
PrO/HyCho cocultures. Then, we examined whether the
cocultures possessed a pool of LTGF- and, if so, whether
it would be activated by exogenous TGase. The results show
that TGF- can stimulate mineralization in the cultures, and
that the cultures do contain a considerable amount of en-
dogenous LTGF-. However, other results suggest that
stimulation of mineralization by TGase is through a mech-
anism that is independent of TGF- or its activation.
That TGF- could stimulate mineralization in the cocul-
tures was demonstrated by the addition of recombinant,
active TGF-2 (200 pg/ml). This resulted in increased min-
eralization (Fig. 7A, compare 200 pg TGF-2 with Con-
trol). For measuring the endogenous TGF- activity in the
cultures, we employed a bioassay for TGF- based on its
ability to induce the expression of plasminogen activator
Fig. 5. Effect of exogenous transglutaminase on osteoblastic differentiation
of PrO cell cultures. (A) RT-PCR analysis of mRNA for bone sialoprotein
(BSP) in control PrO cells and treated with exogenous enzyme (TGase).
(B) Mineralization in 8-day PrO cell cultures to which exogenous TGase
(0.01 U/ml) was added daily. Mineralization was quantified by image
analysis of areas of Alizarin Red staining (the bar shows triplicate cultures
of a representative experiment).
Fig. 6. Electrophoretic analysis of the proteins cross-linked by endogenous
and exogenous TGase in the PrO/HyCho cultures. Cells were grown in the
presence of TGase substrate (1.5 M biotin-pentilamine) for 3 days.
Exogenous transglutaminase was added at 0.01 U/ml (TGase). Cell
lysates separated by SDS-PAGE using 12% gels and analyzed by Western
blot analysis with ExtAvidin-HRP to detect biotinylated proteins.
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Fig. 7. (A) Effect of exogenously added TGF- 2 on mineralization in PrO/HyCho cocultures over a 5-day period. Low levels of TGF- 2 (5–200
pg/ml) promote mineralization, while higher levels of 1–5 ng/ml inhibit it. (B) Endogenous levels of TGF- in 5-day cell cultures of hypertrophic
chondrocytes (HyCho), preosteoblastic cells (PrO), and cocultures, as determined by the TGF- responsive promoter assay. Recombinant TGF-2 was
used to create a standard curve. (C) Levels of endogenous active TGF- in PrO/HyCho cocultures grown with and without exogenously added
transglutaminase (0.01 U/ml).
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inhibitor-1 (PAI-1) (Abe et al., 1994). By this assay, the
secreted active TGF- in the PrO/HyCho cocultures was
somewhat higher than in PrO cell cultures, with the HyCho
cultures having the lowest activity (Fig. 7B, solid bars).
However, in each of the cultures, most of the TGF- was
present in the latent state, as determined by assaying the
culture media following activation of LTGF- by heating
(Abe et al., 1994). Thus, high levels of LTGF- (up to 1
ng/ml) were present in the cocultures that potentially could
be activated by the addition of TGase.
To determine whether, in fact, the addition of TGase did
activate latent TGF-, we analyzed the levels of active
TGF- in the conditioned medium of cocultures to which
exogenous TGase had been added. The results (Fig. 7C)
showed that the addition of exogenous TGase to the cocul-
tures not only failed to increase the level of active TGF-
but instead caused a slight decrease. Therefore, mineraliza-
tion in the PrO/HyCho coculture system can be indepen-
dently regulated by these two mechanisms—one involving
TGase and another involving TGF-.
Interrelationship between TGase and PKA signaling
cAMP-dependent PKA is one major signaling pathway
that previous studies have implicated in mineralization
(Yang and Gerstenfeld, 1996; and see Introduction). To
examine whether TGase affected the PKA signaling path-
way, we first compared the protein and activity levels of
PKA in control, untreated cultures to ones that had been
treated with exogenous TGase. By immunoblotting, the
cultures treated with TGase showed a clear decrease in PKA
protein (Fig. 8A), and by an enzymatic assay involving
phosphate incorporation into a PKA-specific peptide
showed decrease in activity of 55  5% (n  3) (Fig. 8B).
This suggests that, in the cocultures, the exogenous TGase
acts by decreasing the level of PKA-dependent signaling.
The decrease in PKA activity can be detected as early as
3–4 days in the presence of exogenous TGase, while in-
crease in mineralization can be observed beginning from
days 4–5. Thus, downregulation of PKA activity in the
presence of exogenous enzyme precedes the increase in
mineralization and may be causing it.
To determine more directly whether this TGase-induced
decrease in PKA activity was involved in the promotion of
matrix mineralization, we examined the effect of the known
modulators of PKA activity on the levels of mineralization
in the cocultures. For this, we examined the effect of two
inhibitors of PKA (myristoylated cell permeable PKA in-
hibitor 14–22 amide and the sulfonamide inhibitor H-89),
and an activator of PKA (cAMP analog). As predicted,
inhibition of PKA (by either the 14–22 amide or by H-89)
caused an increase in mineralization (Fig. 9A), whereas
activation of PKA (by cAMP analog) resulted in a decrease
in mineralization. Further confirmation of the decrease in
PKA promoting mineralization was obtained by inhibiting
the downstream mediators of PKA signaling, MEK1/2. Ad-
dition of an inhibitor of MEK1/2 (U0126) greatly promoted
mineralization (Fig. 9B). Taken together, these results sug-
gest that one of the mechanisms through which TGase
promotes matrix mineralization is through inhibition of the
PKA-dependent signaling pathway.
Discussion
Coordinated growth of the epiphyseal plate cartilage and
the surrounding sleeve of periosteal bone is a fundamental
characteristic of long bone development. Our previous stud-
ies (Long and Linsenmayer, 1998; DeNino et al., 2001)
suggest that growth and differentiation of the cartilage itself
is regulated by interactions with the surrounding perichon-
drium and periosteum. In the present study, we have de-
tected a reciprocal interaction in which the hypertrophic
chondrocytes (HyCho) of the growth plate, through a
TGase-mediated mechanism(s), regulate mineralization/os-
teogenesis in an advancing bone collar.
The bone collar is derived from the cells of the perios-
teum which differentiate into the osteoblasts that ultimately
produce the mineralized bone matrix. We have observed in
Fig. 8. (A) Effect of exogenous TGase (0.01 U/ml) on the levels of PKA
protein in PrO/HyCho cultures. Cell lysates were separated by SDS-PAGE
using 12% gel, blotted onto PVDF membrane, and PKA was detected by
using polyclonal anti-human PKA antibody (Calbiochem). -Tubulin, de-
tected using anti-mouse -tubulin antibody (Sigma), was used as a loading
control. (B) Enzymatic activity of PKA in the Pro/HyCho cultures is
reduced in the presence of exogenous TGase (0.01 U/ml) (clear bar). The
graph represents data from three independent experiments.
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a rapidly growing bone, such as the embryonic avian tibio-
tarsus, that the advancing sleeve of overtly differentiated
periosteal bone is preceded by a leading edge of nonmin-
eralized tissue. We have cultured and analyzed the cells
from this leading edge and determined that they have al-
ready become committed to osteogenic lineage, as they
synthesize a number of early osteoblastic markers [e.g., the
transcription factor Cbfa1, high levels of alkaline phospha-
tase and the matrix proteins collagen type I, osteonectin and
osteopontin (Quarles et al., 1992; Ducy et al., 1997)]. How-
ever, they have not yet expressed other characteristics in-
dicative of overtly differentiated osteoblasts (e.g., bone sia-
loprotein and osteocalcin) (Raouf and Seth, 2000). We
therefore have termed these cells preosteoblastic (PrO)
cells.
Cultures of these PrO cells themselves undergo some
mineralization, but this is minimal and occurs only after an
extended time in culture. However, their mineralization is
greatly promoted by interactions with hypertrophic chon-
drocytes (HyCho) or, to a lesser extent, by factor(s) secreted
by HyCho. Cocultures of these two cell types undergo rapid
(4–8 days) and extensive mineralization, with the PrO cells
producing the mineralized matrix—most likely reflecting
their differentiation into overt osteoblasts, as they acquire
additional markers indicative of overt osteoblasts—and the
HyCho cells induce this progression.
Previous studies have shown that, under certain condi-
tions (e.g., in the presence of retinoic acid), hypertrophic
chondrocytes can differentiate into osteoblast-like cells, and
after 15–20 days in culture, deposit mineralized matrix
(Descalzi Cancedda et al., 1992; Wang and Kirsch, 2002).
In our cultures, however, several types of evidence suggest
that the osteoblasts are derived from the PrO cells, with no
detectable contribution from the HyCho cells. First of all,
PrO cells themselves can undergo slight mineralization after
8 days, but cultures of HyCho cells fail to show any traces
of mineralization even after 35 days (the longest time ex-
amined). Also, the conditioned medium from cultures of
HyCho cells is able to induce mineralization when added to
cultures of PrO cells, but not the converse. Perhaps most
definitively, in mineralizing cocultures of chicken PrO cells
and mouse chondrocytes, the markers indicative of osteo-
blastic differentiation (e.g., BSP and osteocalcin) are only of
chicken origin. Therefore, in our cocultures, it seems that
the PrO cells are the cell type directly responsible for
producing the mineralized matrix, most likely reflecting
their progression to overt osteoblasts, and the HyCho cells
and their secreted regulators are responsible for promoting
this progression.
The best-characterized regulators of osteoblastic matura-
tion synthesized by chondrocytes are BMPs (Yamaguchi et
al., 2000). Germane to the present study, however, evidence
suggests that other chondrocyte-derived factors can also
regulate osteogenesis. A recent study using the multipotent
mesenchymal cell line C3H10T1/2 (Gerstenfeld et al.,
2002) detected a chondrocyte-derived factor that is different
from BMP, but promotes osteogenesis. Also, we (unpub-
lished observations) have observed that, when the BMP
antagonist noggin is added to PrO/HyCho cocultures, ma-
trix mineralization still occurs, though at a reduced level.
The results presented in this study suggest that TGase is
one of the additional factors secreted by HyCho cells that
effect mineralization in PrO cells. Although both HyCho
and PrO cells synthesize TGases, activity from the former is
considerably greater. Functionally, in PrO/HyCho cocul-
tures, when TGase activity is experimentally increased or
decreased, mineralization is concomitantly altered in a man-
ner indicative of TGase-mediated stimulation of osteogen-
esis. When endogenous TGase is decreased through the
addition of the inhibitor putrescine, mineralization is de-
creased to a third, and since there is no decrease in cell
proliferation, the effect is unlikely due to toxicity. Con-
versely, when total TGase activity is increased through the
addition of exogenous TGase, mineralization is increased 3-
to 5-fold. That the addition of putrescine does not com-
pletely abolish mineralization is consistent with the pres-
ence of other mechanisms that can regulate osteoblastic
differentiation (e.g., BMPs or FGFs) (reviewed by France-
schi, 1999; Ornitz and Marie, 2002).
There are several possible mechanisms through which
TGase could produce this effect on mineralization, and we
have examined a number of these. It could be achieved
Fig. 9. (A) Effect of altered PKA activity on mineralization in PrO/HyCho
cultures. Cells were grown for 5 days in the medium inducing mineraliza-
tion in the presence of 10 M cell-permeable myrisroylated protein kinase
inhibitor 14–22 amide (Calbiochem), 50 nM PKA inhibitor H-89 (Upstate
Biotechnology), or PKA activator 40 M of cAMP analogue, 8-bromo-
cAMP (Calbiochem). Mineralization was detected by Alizarin Red stain-
ing. (B) Effect of inhibiton of MEK1/2 on mineralization. Cells were
grown in the presence of 5 M U0126 (Calbiochem). Mineralization was
quantified by image analysis of areas of Alizarin Red staining (the bar
shows triplicate cultures of a representative experiment).
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either directly by modification of the extracellular matrix
proteins involved in mineralization (reviewed by Aeschli-
mann and Thomazy, 2000), or indirectly by affecting sig-
naling through the activation of LTGF- (Nunes et al.,
1997) or through alterations in PKA signaling (Chen et al.,
1992; Wang et al., 2000; Ouyang et al., 2000).
We did not detect any significant changes in the pattern
of proteins cross-linked by TGase in the PrO/HyCho cul-
tures in the presence of exogenously added enzyme com-
pared with untreated cultures. Although this does not defin-
itively eliminate a mechanism involving modification of
extracellular proteins, it makes it less likely.
The TGF-s are the only class of signaling molecules
that have been reported to regulate osteogenesis—both pos-
itively and negatively—and whose activity can, in turn, be
regulated by the TGases (see Introduction). We have ob-
served in our cocultures that TGF-2 can effect positive
regulation of mineralization. When we added an amount of
recombinant TGF-2 equivalent to that which we had de-
termined to be already present and active in the culture (200
pg/ml)—giving a total concentration of active factor of 400
pg/ml—mineralization was increased up to 3-fold. How-
ever, the addition of large amounts of the recombinant
factor (over 1 ng/ml) resulted in a decrease in mineralization
(unpublished data). Therefore, mineralization in the Pro/
HyCho cocultures is responsive to TGF-, with the concen-
tration of active factor determining whether this is stimula-
tion or inhibition.
We also determined that a large pool of latent TGF- (up
to 1 ng/ml) was present in the cocultures, in agreement with
previous studies on chondrocyte cultures (Boyan et al.,
1994; D’Anegelo et al., 2001). Therefore, it is possible that
activation of this latent TGF- is the mechanism through
which addition of exogenous TGase produces the observed
increase in mineralization. However, in the cocultures
treated with TGase, our analyses detected no increase in
TGF- activity. Thus, it seems that TGase promotes matrix
mineralization through a mechanism(s) that is independent
of the TGF- signaling pathway.
Previous studies have implicated intracellular signaling
pathways in regulating mineralization. One of these is
cAMP-dependent protein kinase (PKA) (see Introduction)
and the other is Ca2-dependent protein kinase (PKC)
(Ouyang et al., 2000). Both pathways mediate signaling by
parathyroid hormone-related protein, and, as such, are in-
volved in the development and maintenance of mineralized
tissues.
In the present studies, we examined whether PKC was
involved in the observed TGase-mediated regulation of
mineralization. However, we could detect no effect of levels
of total PKC activity in the TGase-treated cell cultures
versus untreated. Therefore, this possibility was not pursued
further.
Instead, all of our results are consistent with the TGase-
mediated effects on mineralization in the cocultures and the
differentiation of the PrO cells being regulated, at least in
part, through the PKA pathway. These observations are: (1)
that exogenous TGase both causes a decrease in PKA pro-
tein and enzymatic activity and subsequently promotes min-
eralization, (2) inhibitors of PKA and inhibitors of the
downstream mediators of the PKA pathway (MEK1/2) all
increase mineralization, and (3) activation of PKA inhibits
mineralization. These observations are consistent with pre-
vious reports by others, which indicate that in osteoblast
cells, activation of the PKA pathway suppresses mineral-
ization (Tintut et al., 1999, Wang et al., 2000), and that in
cementoblasts, the negative affect of PTHrP is mediated
through activation of PKA (Ouyang et al., 2000). The exact
mechanisms of the TGase-mediated regulation of PKA ac-
tivity remain to be understood.
During the development of an endochondral bone, the
elongation of the periosteal bone is coordinated with the
progression of the epiphyseal growth cartilage. The results
of the present study—when coupled with previous observa-
tions from our laboratory and others—suggest that one
mechanism of this coordination involves a regulatory influ-
ence from the HyCho cells. These cells, and products re-
leased by them, influence the overlying sleeve of nonmin-
eralized, preosteoblastic tissue to undergo mineralization
and the PrO cells to differentiate into overt osteoblasts.
Furthermore, at least part of this regulation involves TGase
released by the HyCho cells upon their death (Nurminskaya
et al., 1998). This TGase, in turn, promotes mineralization
and differentiation of the PrO cells of the overlaying peri-
osteal bone. One of the mechanisms through which the
TGase affects mineralization is via PKA by decreasing the
activity of this pathway, which we have observed, is an
inhibitor of mineralization in the cultures.
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